Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • United States

    Tag: United States

    You Searched For "United States"
    Strides Pharma suspends sale of Ranitidine tab in US

    Strides Pharma suspends sale of Ranitidine tab in US

    Medical Dialogues Bureau27 Sept 2019 9:56 AM IST
    New Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 1:32 PM IST
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Medical Dialogues Bureau6 July 2019 9:15 AM IST
    Xofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Farhat Nasim28 Jun 2019 11:10 AM IST
    The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
    Dr Reddys unveils generic version of Vitamin K1 injection in US

    Dr Reddys unveils generic version of Vitamin K1 injection in US

    Medical Dialogues Bureau25 Jun 2019 10:52 AM IST
    The Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
    GSK eyes sale of $1.2 billion consumer health drugs; says report

    GSK eyes sale of $1.2 billion consumer health drugs; says report

    Medical Dialogues Bureau22 Jun 2019 8:59 AM IST
    GSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
    AHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
    Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

    Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

    Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
    Online pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan,...
    Novartis

    Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report

    Medical Dialogues Bureau13 Jun 2019 10:03 AM IST
    The U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Medical Dialogues Bureau12 Jun 2019 9:30 AM IST
    Roche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Medical Dialogues Bureau11 Jun 2019 9:30 AM IST
    Polivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    Medical Dialogues Bureau8 Jun 2019 10:00 AM IST
    The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok